Sanofi Didn’t Follow Protocol for Clinical Trial in Which Infant Died

Sanofi shut down its RSV vaccine trial for infants and toddlers in 2024 after a baby died. It was later determined that the baby had an underlying congenital heart defect, which should have disqualified the infant from participating in the trial. A letter obtained through a Freedom of Information request reveals that Sanofi told the operators of its clinical trial sites that it paused the trial “to re-educate all participating sites and investigators” on the criteria for determining eligibility for participating in the trials. Full  Story Here  https://childrensh/rsv-vaccine-clinical-trial-infant-death-